Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Personalis (PSNL) Cash & Current Investments (2017 - 2026)

Personalis has reported Cash & Current Investments over the past 9 years, most recently at $240.0 million for Q4 2025.

  • For Q4 2025, Cash & Current Investments rose 29.7% year-over-year to $240.0 million; the TTM value through Dec 2025 reached $240.0 million, up 29.7%, while the annual FY2025 figure was $240.0 million, 29.7% up from the prior year.
  • Cash & Current Investments for Q4 2025 was $240.0 million at Personalis, up from $150.5 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $353.4 million in Q1 2021 and troughed at $87.0 million in Q2 2024.
  • A 5-year average of $195.8 million and a median of $179.1 million in 2024 define the central range for Cash & Current Investments.
  • Biggest five-year swings in Cash & Current Investments: soared 212.55% in 2021 and later tumbled 44.12% in 2023.
  • Year by year, Cash & Current Investments stood at $287.1 million in 2021, then crashed by 41.6% to $167.7 million in 2022, then tumbled by 31.9% to $114.2 million in 2023, then skyrocketed by 62.03% to $185.0 million in 2024, then rose by 29.7% to $240.0 million in 2025.
  • Business Quant data shows Cash & Current Investments for PSNL at $240.0 million in Q4 2025, $150.5 million in Q3 2025, and $173.2 million in Q2 2025.